News
January 2007
Cannabis Drug May Help Fight Obesity
30 January 2007 :Human trials of an experimental
treatment for obesity derived from cannabis, which is commonly associated
with stimulating hunger, are scheduled to begin in the second half of
this year...
Read More...
Patients
Overeat To Qualify For Weight Surgery
25 January 2007 :Some obese people are eating
more fatty foods to qualify for weight reduction surgery on the NHS, a
health charity claimed yesterday...
Read More...
Erectile Dysfunction Drugs Safe, Effective for Diabetic Men
24 January 2007 :Three drugs used to treat
erectile dysfunction - Cialis,
Levitra and Viagra
- are safe and effective for men with diabetes, concludes a research review
in the current issue of the Cochrane Library journal....
Read More...
Viagra
May Decrease Ability To Smell
18 January 2007 :Higher doses of Viagra
(sildenafil) may impair the ability to smell, which is possibly related
to an increase in nasal congestion....
Read More...
Age-related Impotence May Improve Over Time
16 January 2007 :About one third of older
men who are impotent (men with erectile dysfunction) will experience natural
remission, with symptoms becoming less severe but not necessarily going
away completely, research suggests....
Read More...
Viagra
Could Be Prescribed Over Counters
12 January 2007 :Pfizer Inc. has said it
is considering an over-the-counter form of its Viagra anti-impotence drug
as it faces tough competition from Eli Lilly and Co.'s longer-acting Cialis
treatment....
Read More...
Common Cold Virus Could Destroy Cancer Tumours
11 January 2007 :The common cold could be
used in a ground-breaking treatment to fight cancer, scientists said last
night....
Read More...
Recent diet drugs
need more reviews to mark their Benifits and Risks
05 January 2007 :Millions of Americans take
popular drugs to lose weight, but the long-term risks and benefits of
these medications aren't known...
Read More...
Eli Lilly Confirms UK Plant Closure
02 January 2007 :Giant drug maker Eli Lilly
has confirmed that it will be closing its manufacturing facility in Basingstoke,
England, resulting in $85m to $95m in restructuring costs for the company....
Read More...
|
